Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Effect of 1, 25-dihydroxyvitamin D3 on T-Helper 17 (TH17) cell pathways in diarrhea-associated irritable bowel syndrome

Yongjian Li, Yan Wang

Department of Pediatrics, Hangzhou Ninth Peoples Hospital, Qiantang District, Hangzhou City, Zhejiang Province 311225, China;

For correspondence:- Yan Wang Email: wangyan_wytg55@163.com Tel:+8657182906245

Accepted: 23 March 2024 Published: 30 April 2024

Citation: Li Y, Wang Y. Effect of 1, 25-dihydroxyvitamin D3 on T-Helper 17 (TH17) cell pathways in diarrhea-associated irritable bowel syndrome. Trop J Pharm Res 2024; 23(4):747-752 doi: 10.4314/tjpr.v23i4.10

© 2024 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the effect of 1, 25-dihydroxyvitamin D3 (1,25-(OH)2D3) on T-Helper 17 (TH17) cell pathways in diarrhea-associated irritable bowel syndrome (IBS-D).

Methods: 120 children with IBS-D were treated with Smecta alone and Smecta in addition to 1,25-(OH)2D3 in Hangzhou Ninth Peoples Hospital, Hangzhou, China. Blood samples were taken to determine the levels of 1,25-(OH)2D3, IL-17, IFN-γ, IL-23, and IL-6, as well as Th17 cell ratio. Furthermore, IL-17 and RORγt expressions were evaluated.

Results: Serum 1,25-(OH)2D3 levels decreased in IBS-D patients and were negatively correlated with IL-17 levels in serum and Th17 cells in peripheral blood. Treatment with 1,25-(OH)2D3 significantly reduced serum IFN-γ, IL-17, IL-23 and IL-6 levels in IBS-D patients (p < 0.05). Percentage of Th17 cells, and IL-17 and RORγt expression levels were significantly reduced in IBS-D patients after 1,25-(OH)2D3 treatment (p < 0.05).

Conclusion: This study shows that 1,25-(OH)2D3 reduces serum IFN-γ, IL-17, IL-23, IL-6 levels, Th17 cells and RORγt expression in IBS-D patients. Additional studies with larger sample sizes are required to validate these findings.

Keywords: Diarrhea irritable bowel syndrome, 1,25-Dihydroxyvitamin D3, Th17 cells, IL-17, ROR?t